YUNGZIP Business Summary

Yung Zip Chemical Ind. Co., Ltd. (4102.TWO) is a premier Taiwan-based manufacturer specializing in Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. The company operates a diversified revenue model centered on high-margin API production (58.5% of revenue), Contract Development and Manufacturing Organization (CDMO) services (26.8%), and health supplement contract manufacturing via its subsidiary, Taiwan WayChein Industrial (14.5%). As the first API manufacturer in Taiwan to implement GMP standards, Yung Zip maintains a robust international footprint with certifications from the US FDA, MHRA, and PMDA. It competes directly with regional peers such as SYN-Tech Chem & Pharm (1777), Nang Kuang Pharmaceutical (1752), and Chunghwa Chemical Synthesis & Biotech (1762), positioning itself as a high-reliability technical partner within the global pharmaceutical supply chain. The company was founded in 1978 by Fang-yu Lee, a key figure in the legacy YungShin Group, to localize API development for the Taiwanese market. As of March 2026, the leadership team is headed by Chairman Lin Ching Hwang, an accounting and management veteran with over 15 years of industry experience, and General Manager Li Yu-Ru, whose role was recently reaffirmed by the board to oversee strategic expansions in the Greater China region. The board includes influential figures such as Lee Fang Chen, PhD, who brings deep expertise in medicinal chemistry and intellectual property. Yung Zip remains a strategic cornerstone of the YungShin Global Holding Corp (3705.TW) ecosystem, benefiting from the parent group's extensive distribution networks and multi-continental manufacturing infrastructure.